Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Isis Paez"'
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 742 (2023)
Statins are currently the treatment of choice for hypercholesterolemia. However, wide interindividual variability has been observed in the response to treatment. Recent studies have reported the role of lncRNAs in the metabolism of lipids; neverthele
Externí odkaz:
https://doaj.org/article/5e2143f9ddfa4b44a7a97f6c204c01f5
Autor:
Carmen Gloria Ubilla, Yalena Prado, Jeremy Angulo, Ignacio Obreque, Isis Paez, Nicolás Saavedra, Kathleen Saavedra, Tomás Zambrano, Luis A. Salazar
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Evidence accumulated so far indicates that circulating levels of microRNAs (miRNAs) are associated with several pathologies. Therefore, differential expression of extracellular miRNAs exhibits promising potential for screening and diagnosis purposes.
Externí odkaz:
https://doaj.org/article/c9f8c3b5acd54efcbb87e454a28a165b
Publikováno v:
Pharmaceuticals, Vol 13, Iss 11, p 382 (2020)
Atorvastatin is extensively used to treat hypercholesterolemia. However, the wide interindividual variability observed in response to this drug still needs further elucidation. Nowadays, the biology of long non-coding RNAs (lncRNAs) is better underst
Externí odkaz:
https://doaj.org/article/8f71117b2ba9446b84a8d5e42e74062b
Autor:
Kathleen Saavedra, Karla Leal, Nicolás Saavedra, Yalena Prado, Isis Paez, Carmen G. Ubilla, Gabriel Rojas, Luis A. Salazar
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 5022
The treatment of hypercholesterolemia is mainly based on statins. However, the response to pharmacological therapy shows high inter-individual variability, resulting in variable effects in both lipid lowering and risk reduction. Thus, a better unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2202f02514f626cf9aac25bca59631ef
Autor:
Ignacio Obreque, Carmen Gloria Ubilla, Kathleen Saavedra, Jeremy Angulo, Luis A. Salazar, Nicolás Saavedra, Yalena Prado, Tomás Zambrano, Isis Paez
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Evidence accumulated so far indicates that circulating levels of microRNAs (miRNAs) are associated with several pathologies. Therefore, differential expression of extracellular miRNAs exhibits promising potential for screening and diagnosis purposes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35efb9226ca0096f433a495a7ea319f3
https://www.frontiersin.org/articles/10.3389/fphar.2021.674252/full
https://www.frontiersin.org/articles/10.3389/fphar.2021.674252/full
Publikováno v:
Pharmaceuticals, Vol 13, Iss 382, p 382 (2020)
Pharmaceuticals
Volume 13
Issue 11
Pharmaceuticals
Volume 13
Issue 11
Atorvastatin is extensively used to treat hypercholesterolemia. However, the wide interindividual variability observed in response to this drug still needs further elucidation. Nowadays, the biology of long non-coding RNAs (lncRNAs) is better underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5ce55c1e1ab76dea2bdd5c6ee5e4fa2
https://www.mdpi.com/1424-8247/13/11/382
https://www.mdpi.com/1424-8247/13/11/382
Autor:
Pía Loren, Yuliannis Lugones, Nicolás Saavedra, Kathleen Saavedra, Isis Páez, Nelia Rodriguez, Patricia Moriel, Luis A. Salazar
Publikováno v:
Biomolecules, Vol 12, Iss 9, p 1206 (2022)
Cisplatin (cis-diamminedichloroplatinum (II), DDP) is an antineoplastic agent widely used in the treatment of solid tumors because of its extensive cytotoxic activity. However, the main limiting side effect of DDP use is nephrotoxicity, a rapid deter
Externí odkaz:
https://doaj.org/article/a31020eba7b7417db045dc2af4ce4834